NCT00539240 - Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI | Biotech Hunter

Enrollment

236

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

November 30, 2011

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Rabeprazole 20mg, placebo dinner and bedtime

Breakfast study medication - Rabeprazole 20mg, matching placebo at dinner , Placebo for tricyclic antidepressant at bedtime

DRUG

Rabeprazole 20 mg two times, Placebo at bedtime

Breakfast \& Dinner study medication - Rabeprazole, placebo for tricyclic antidepressant at bedtime

DRUG

Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant

Rabeprazole (Breakfast) study medication, dinner placebo medication, tricyclic antidepressant at bedtime

Trial Locations (1)

Southern Arizona VA Health Care System, Tucson, Tucson

All Listed Sponsors

lead

US Department of Veterans Affairs

FED